Evidence map›Paper›PMID 36952551›Full record

ArticleBlood advances2023

Characterization of the human platelet N- and O-glycome upon storage using tandem mass spectrometry.

Katelyn E Rosenbalm, Melissa M Lee-Sundlov, David J Ashline, Renata Grozovsky, Kazuhiro Aoki, Andrew J S Hanneman, Karin M Hoffmeister

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. The glycan fingerprint in immune thrombocytopenia.Research and practice in thrombosis and haemostasis · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Effects of two different variants in theFrontiers in immunology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Katelyn E RosenbalmTranslational Glycomics Center, Versiti Blood Research Institute, Milwaukee, WI.
Melissa M Lee-SundlovTranslational Glycomics Center, Versiti Blood Research Institute, Milwaukee, WI.
David J AshlineThe Glycomics Center, Division of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH.
Renata GrozovskyDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL.
Kazuhiro AokiDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0003-0029-4291
Andrew J S HannemanTranslational Glycomics Center, Versiti Blood Research Institute, Milwaukee, WI.
Karin M HoffmeisterTranslational Glycomics Center, Versiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0001-6526-7919
Versiti Blood Center of Wisconsin · USMedical College of Wisconsin · USNew England Biolabs (United States) · USUniversity of Miami · USUniversity of New Hampshire · US

Funding

REGULATION OF LACTOSAMINYL GLYCAN BIOSYNTHESIS IN HEMATOPOIETIC CELLSP01HL107146 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI RHEINHOLD, VERN · 2011 to 2017
$17.7M
Project 3: Role of Glycosaminoglycans in HematopoiesisP01HL151333 · NHLBI · VERSITI WISCONSIN, INC. · PI HOFFMEISTER, KARIN MARIA · 2021 to 2025
$12.3M
Carbohydrate-Mediated Platelet ClearanceR01HL089224 · NHLBI · VERSITI WISCONSIN, INC. · PI Karin Maria Hoffmeister · 2007 to 2026
$9.3M
Glycans in Blood Homeostasis and DiseaseK12HL141954 · NHLBI · VERSITI WISCONSIN, INC. · PI DAHMS, NANCY M., DESAI, UMESH RAMANLAL · 2018 to 2022
$4.9M
Biobehavioral Oncology Training ProgramT32CA269115 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Jennifer Mary KNIGHT, Melinda R Stolley · 2023 to 2026
$1.2M
NCI NIH HHS T32 CA269115NHLBI NIH HHS K12 HL141954NHLBI NIH HHS P01 HL107146NHLBI NIH HHS P01 HL151333NHLBI NIH HHS R01 HL089224
6 · The paper itself

Abstract

Changes in surface glycan determinants, specifically sialic acid loss, determine platelet life span. The gradual loss of stored platelet quality is a complex process that fundamentally involves carbohydrate structures. Here, we applied lipophilic extraction and glycan release protocols to sequentially profile N- and O-linked glycans in freshly isolated and 7-day room temperature-stored platelet concentrates. Analytical methods including matrix assisted laser desorption/ionization time-of-flight mass spectrometry, tandem mass spectrometry, and liquid chromatography were used to obtain structural details of selected glycans and terminal epitopes. The fresh platelet repertoire of surface structures revealed diverse N-glycans, including high mannose structures, complex glycans with polylactosamine repeats, and glycans presenting blood group epitopes. The O-glycan repertoire largely comprised sialylated and fucosylated core-1 and core-2 structures. For both N- and O-linked glycans, we observed a loss in sialylated epitopes with a reciprocal increase in neutral structures as well as increased neuraminidase activity after platelet storage at room temperature. The data indicate that loss of sialylated glycans is associated with diminished platelet quality and untimely removal of platelets after storage.

Indexed as

Blood PlateletsTandem Mass SpectrometryEpitopesHumansPolysaccharidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationEpitopesPolysaccharides

Identifiers

PMID36952551
PMCPMC10424148
OpenAlexW4360609079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.